Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders Ehninger D; Silva AJTrends Mol Med 2011[Feb]; 17 (2): 78-87Tuberous sclerosis (TSC) is a genetic disorder caused by heterozygous mutations in the TSC1 or TSC2 genes and is associated with autism spectrum disorders (ASD) in 20-60% of cases. In addition, altered TSC/mTOR signaling is emerging as a feature common to a subset of ASD. Recent findings, in animal models, show that restoration of the underlying molecular defect can improve neurological dysfunction in several of these models, even if treatment is initiated in adult animals, suggesting that pathophysiological processes in the mature brain contribute significantly to the overall neurological phenotype in these models. These findings suggest that windows for therapeutic intervention in ASD could be wider than thought previously.|Animals[MESH]|Child[MESH]|Child Development Disorders, Pervasive/*drug therapy[MESH]|Humans[MESH]|Mutation[MESH]|Signal Transduction[MESH]|Sirolimus/*therapeutic use[MESH]|TOR Serine-Threonine Kinases/genetics/metabolism[MESH]|Tuberous Sclerosis Complex 1 Protein[MESH]|Tuberous Sclerosis/*drug therapy[MESH]|Tumor Suppressor Proteins/genetics/metabolism[MESH] |